Search for: "Grant v. Bristol-Myers Squibb"
Results 61 - 80
of 157
Sorted by Relevance
|
Sort by Date
18 Jan 2017, 10:19 am
(relisted after the January 6 and January 13 conferences) Bristol-Myers Squibb Co. v. [read post]
15 May 2014, 11:40 am
I accept that, for the reasons explained by Jacob J in Bristol-Myers Squibb and Lord Hoffmann in Kirin-Amgen, courts should be cautious before relying upon prosecution history as an aid to construction. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
28 Oct 2014, 3:14 pm
Bristol-Myers Squibb, Inc., 750 F.3d 111, 111 (1st Cir. 2014). [read post]
25 May 2021, 3:00 am
Generally, most of our analysis came from the multitude of court cases involving personal jurisdiction (e.g., International Shoe, Bristol-Myers Squibb, Daimler A.G., etc.). [read post]
15 Apr 2020, 8:46 am
Rather than rely, as many courts have, on the Supreme Court’s recent decision in Bristol Myers Squibb v. [read post]
3 Mar 2012, 5:36 pm
Bristol-Myers Squibb, 97 F. [read post]
27 Apr 2009, 9:43 am
Bristol-Myers Squibb Co., 25 No. 3 Andrews Pharmaceutical Litig. [read post]
4 Jan 2019, 9:16 pm
On December 5, 2018, the General Court ruled in favor of the European Commission in an action brought by Bristol-Myers Squibb Pharma (BMS) against the Commission and the European Medicines Agency (EMA) in the case, T‑329/16, read here. [read post]
26 May 2015, 7:42 am
Bristol-Myers Squibb Co., 2011 WL 4708850 (D. [read post]
4 Mar 2014, 10:00 am
Bristol Myers Squibb Co., 2014 U.S. [read post]
8 Apr 2016, 9:14 am
(“Merial”) and Bristol-Myers Squibb(“BMS”) (together, “appellees”). [read post]
20 Jun 2017, 4:29 am
And in Bristol-Myers Squibb Co. v. [read post]
4 Oct 2019, 10:55 am
Noting that the First Circuit has not addressed the question, the court described two divergent approaches taken by district courts around the country on the personal jurisdiction issue: some courts, with which the Chavira court agreed, have ruled that the Supreme Court’s decision in Bristol-Myers Squibb Co. v. [read post]
18 Aug 2010, 12:19 am
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) Reyataz (Atazanavir): US: Patent infringement complaint filed following a Paragraph IV certification: Bristol-Myers Squibb Co. et al. v. [read post]
30 Jun 2017, 4:14 am
At The Washington Legal Foundation’s Legal Pulse blog, Richard Samp discusses Bristol-Myers Squibb Co. v. [read post]
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
22 Jan 2019, 2:09 am
One case, Bristol-Myers Squibb Co. v. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP… [read post]
